BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

NCT00526149 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer
Endometrial Cancer
Head and Neck Cancer
Melanoma (Skin)
Ovarian Cancer
Sarcoma

Interventions

DRUG: BI 2536
OTHER: high performance liquid chromatography
OTHER: mass spectrometry
OTHER: pharmacological study

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC